Corden Pharma International GmbH – Trademark Portfolio
Entity Type: 99
Corden Pharma International GmbH holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 4 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include BOTANICHOL and CORDEN PHARMA.
Otto-Hahn-Strasse
68723 Plankstadt
Showing of trademarks Trademarks
Trademark Classifications
Corden Pharma International GmbH's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Corden Pharma International GmbH have?
Corden Pharma International GmbH has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending, 1 abandoned.
What trademark classes does Corden Pharma International GmbH file in?
Corden Pharma International GmbH files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 40 (Treatment & Processing), Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Corden Pharma International GmbH's most well-known trademarks?
Corden Pharma International GmbH's registered trademark portfolio includes well-known marks such as BOTANICHOL and CORDEN PHARMA. These are among 3 currently registered trademarks in the portfolio.
What is Corden Pharma International GmbH's trademark registration success rate?
Corden Pharma International GmbH has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.